Antidepressant Recall: The FDA upgrades the drug risk class to the second highest level in the recall update

The US Food and Drug Administration has recalled thousands of bottles of antidepressants because the drugs contained high levels of a cancer-causing chemical. Now the FDA is assigning the second highest risk level to the recall of duloxetine extended-release capsules…